Continuation of high-dose vancomycin despite nephrotoxicity

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3470-3471

  Teng, Christine B ^a   Rezai, Katayoun ^b   Itokazu, Gail S ^c   Xamplas, Renee C ^c   Glowacki, Robert C ^c   Rodvold, Keith A ^c   Weinstein, Robert A ^b   Schwartz, David N ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLINICAL ARTICLE; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; LETTER; MALE; NEPHROTOXICITY; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; KIDNEY DISEASES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84861150272     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00240-12     Document Type: Letter

References (4)

1. Bosso JA, et al. 2011. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob. Agents Chemother. 55:5475-5479.
2. Prabaker KK, Tran TP, Pratummas T, Goetz MB, Graber CJ. 2012. Elevated vancomycin trough is not associated with nephrotoxicity among inpatient veterans. J. Hosp. Med. 7:91-97.
3. Pritchard L, et al. 2010. Increasing vancomycin serum trough concentration and incidence of nephrotoxicity. Am. J. Med. 123:1143-1149.
4. Wong-Beringer A, Joo J, Tse E, Beringer P. 2011. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int. J. Antimicrob. Agents 37:95-101.